In addition, more efforts should be encouraged on further categorizing the pathogenicity of VUS, such as the recurrent BRCA2 c.8971 C > T in the cancer cohort and the potential splicing abnormalities causing BRCA1 c.548-15G > A in the healthy group. Here, BRCA2 is linked to cancer.